Wall Street Zen Upgrades Cognex (NASDAQ:CGNX) to Buy

Key Points

• Wall Street Zen upgraded Cognex from Hold to Buy, adding to a generally bullish analyst backdrop that now includes a consensus rating of Moderate Buy and a consensus price target of $67.21.
• Cognex reported strong Q1 results, with EPS of $0.34 and revenue of $268.44 million, both topping estimates; revenue also rose 24.3% year over year.
• Management issued upbeat Q2 guidance for EPS of $0.40 to $0.44 and revenue of $280 million to $300 million, reinforcing expectations for continued demand strength in automation and logistics.

Cognex (NASDAQ:CGNX - Get Free Report) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Saturday.

CGNX has been the subject of a number of other reports. The Goldman Sachs Group upped their target price on shares of Cognex from $50.00 to $68.00 and gave the company a "buy" rating in a report on Tuesday, February 17th. Raymond James Financial reaffirmed a "strong-buy" rating on shares of Cognex in a report on Thursday, February 12th. Needham & Company LLC raised their target price on Cognex from $67.00 to $75.00 and gave the stock a "buy" rating in a report on Friday. Barclays raised their target price on Cognex from $61.00 to $64.00 and gave the stock an "overweight" rating in a report on Monday, March 16th. Finally, Sanford C. Bernstein reaffirmed an "outperform" rating and issued a $75.00 target price on shares of Cognex in a report on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $67.21.

Cognex Stock Performance

Cognex stock opened at $65.66 on Friday. The stock has a market cap of $10.97 billion, a PE ratio of 78.17 and a beta of 1.48. Cognex has a one year low of $29.00 and a one year high of $71.90. The stock has a fifty day moving average of $52.67 and a 200 day moving average of $45.20.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.09. The company had revenue of $268.44 million during the quarter, compared to analysts' expectations of $245.98 million. Cognex had a return on equity of 10.89% and a net margin of 13.62%.Cognex's revenue for the quarter was up 24.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.14 earnings per share. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. As a group, sell-side analysts predict that Cognex will post 0.97 EPS for the current fiscal year.

Insiders Place Their Bets

In other Cognex news, Director Angelos Papadimitriou sold 4,150 shares of the stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $55.58, for a total value of $230,657.00. Following the completion of the sale, the director owned 16,222 shares in the company, valued at approximately $901,618.76. This represents a 20.37% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Laura Ann Macdonald sold 14,881 shares of the stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $57.16, for a total value of $850,597.96. Following the completion of the sale, the vice president owned 2,212 shares of the company's stock, valued at $126,437.92. The trade was a 87.06% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 196,083 shares of company stock worth $11,419,321. Corporate insiders own 1.70% of the company's stock.

Institutional Investors Weigh In On Cognex

A number of institutional investors have recently bought and sold shares of CGNX. Royal Bank of Canada boosted its holdings in shares of Cognex by 13.2% during the 1st quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company's stock valued at $5,976,000 after purchasing an additional 23,326 shares during the last quarter. Empowered Funds LLC purchased a new stake in shares of Cognex during the 1st quarter valued at about $291,000. Intech Investment Management LLC raised its position in shares of Cognex by 24.1% during the 1st quarter. Intech Investment Management LLC now owns 47,444 shares of the scientific and technical instruments company's stock valued at $1,415,000 after buying an additional 9,223 shares in the last quarter. Geneos Wealth Management Inc. raised its position in shares of Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock valued at $27,000 after buying an additional 736 shares in the last quarter. Finally, Cetera Investment Advisers raised its position in shares of Cognex by 7.5% during the 2nd quarter. Cetera Investment Advisers now owns 13,208 shares of the scientific and technical instruments company's stock valued at $419,000 after buying an additional 920 shares in the last quarter. Hedge funds and other institutional investors own 88.12% of the company's stock.

Key Stories Impacting Cognex

Here are the key news stories impacting Cognex this week:

• Positive Sentiment: Cognex reported Q1 earnings of $0.34 per share, beating estimates, while revenue came in at $268.4 million, also above expectations and up 24.3% year over year.
• Positive Sentiment: Management issued bullish Q2 guidance for EPS of $0.40 to $0.44 and revenue of $280 million to $300 million, signaling continued demand strength in automation and logistics.
• Positive Sentiment: Analysts turned more constructive after the report: Needham raised its price target to $75 and kept a Buy rating, while Stephens also lifted its target to $75 with an Overweight rating.
• Positive Sentiment: The company’s new AI-powered In-Sight systems and broad-based demand strength are reinforcing the view that Cognex can sustain growth and margin expansion.
• Neutral Sentiment: JPMorgan raised its price target to $65 but maintained a Neutral rating, suggesting some analysts still see limited upside after the recent run-up. Benzinga
• Neutral Sentiment: The company also declared a quarterly dividend of $0.085 per share, a modest positive for income-focused investors.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.